Psychopharmacology is the scientific study of the use of pharmacological compounds in the treatment of mental disorders. Physicians and other prescribers with expertise in psychopharmacology apply their knowledge of pharmacokinetics (what the body does to medication) and pharmacodynamics (what the medications do to the body) in finding optimal medication regimens in treating mental health conditions such as depression, bipolar disorder, schizophrenia, post-traumatic stress disorder, etc.

 

OUR MEETINGS

ASCP organizes four major meetings per year. The Fall and Spring Update on Psychopharmacology: State of the Art meetings (East and West coast) bring together a number of outstanding psychopharmacologists to educate participants about the latest developments in the field.  

The ASCP Annual Meeting brings together over 1200 academic and industry investigators, research pharmacists, clinicians and representatives from regulatory agencies to discuss newer treatments and facilitate collaborations. Finally, ASCP co-sponsors with the Zucker Hillside Hospital an annual Workshop on Clinical Trials. This intensive two-day workshop is the “how to” of designing and running clinical trials.  

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is ASCP’s official journal. It is published by Physicians Postgraduate Press (PPP). All content in the Journal is copyrighted by PPP. Each month, ASCP contributes “ASCP Corner” to the Journal. The Corner contains short evidence-based discussions on clinical psychopharmacology, and periodically contains news of the Society and announcements of Society meetings and activities.  Current ASCP members receive an online subscription to the journal as part of their membership.

ASCP MEMBERSHIP

Founded in 1992, American Society of Clinical Psychopharmacology (ASCP) is a premier international organization that works to advance the science, education and practice of clinical psychopharmacology. It comprises of over 1,200 members from all regions of the world, who are advocates for rational clinical psychopharmacology and for clinical research to develop better treatments to treat mental health conditions.